ScoreRheumatology, allergy and dermatology
ASDAS-ESR (axial spondyloarthritis activity)
Version of ASDAS that uses the erythrocyte sedimentation rate instead of CRP.
Updated 31 October 2026
When to use it
Follow-up of axial spondyloarthritis when CRP is not available.
What it needs
- Back pain (0–10)
- Duration of morning stiffness (0–10)
- Patient global assessment (0–10)
- Peripheral pain or swelling (0–10)
- Erythrocyte sedimentation rate
How to interpret it
| Result | Interpretation |
|---|---|
| < 1.3 | Inactive disease (< 1.3) |
| 1.3 to < 2.1 | Low disease activity (1.3 to < 2.1) |
| 2.1 to < 3.6 | High disease activity (2.1–3.5) |
| ≥ 3.6 | Very high disease activity (> 3.5) |
Practical tip
ASAS prefers the CRP version; ASDAS-ESR and ASDAS-CRP are not interchangeable when following the same patient.
3 more practical tips in the app.
Reference
- Lukas C, Landewé R, Sieper J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68(1):18-24.
- Machado P, Landewé R, Lie E, et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis. 2011;70(1):47-53.
- Machado PM, Landewé R, van der Heijde D; Assessment of SpondyloArthritis international Society (ASAS). Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states. Ann Rheum Dis. 2018;77(10):1539-1540.
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
